BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8734631)

  • 1. Alprostadil for the treatment of erectile dysfunction.
    Kupecz D
    Nurse Pract; 1996 May; 21(5):143-5. PubMed ID: 8734631
    [No Abstract]   [Full Text] [Related]  

  • 2. [Erectile dysfunction].
    Lyngdorf P
    Ugeskr Laeger; 2002 Oct; 164(41):4779-83. PubMed ID: 12407881
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug treatment of sexual disorders in men].
    Slob AK; Gianotten WL
    Ned Tijdschr Geneeskd; 1996 Oct; 140(41):2029-32. PubMed ID: 8965939
    [No Abstract]   [Full Text] [Related]  

  • 4. The early use of transurethral alprostadil after radical prostatectomy potentially facilitates an earlier return of erectile function and successful sexual activity.
    Raina R; Pahlajani G; Agarwal A; Zippe CD
    BJU Int; 2007 Dec; 100(6):1317-21. PubMed ID: 17850385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure to attain stretched penile length after intracavernosal injection of a vasodilator agent is predictive of veno-occlusive dysfunction on penile duplex Doppler ultrasonography.
    Yafi FA; Libby RP; McCaslin IR; Sangkum P; Sikka SC; Hellstrom WJ
    Andrology; 2015 Sep; 3(5):919-23. PubMed ID: 26235901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erectile dysfunction--vasomotor actions of PGE1, its metabolites and other prostaglandins.
    Schrör K
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():533-8. PubMed ID: 7732902
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of erectile responses to vasoactive drugs by a variable amplitude oscillation device.
    Chun SS; Fenemore J; Heaton JP; Johnston B; Morales A
    Int J Impot Res; 1996 Dec; 8(4):221-5. PubMed ID: 8981171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drugs for impotence].
    Lukkarinen O; Pelkonen R
    Duodecim; 1995; 111(8):771-6. PubMed ID: 8681837
    [No Abstract]   [Full Text] [Related]  

  • 9. Intracavernous injection of alprostadil for erectile dysfunction.
    Med Lett Drugs Ther; 1995 Sep; 37(958):83-4. PubMed ID: 7674992
    [No Abstract]   [Full Text] [Related]  

  • 10. Erectile response to transurethral alprostadil, prazosin and alprostadil-prazosin combinations.
    Peterson CA; Bennett AH; Hellstrom WJ; Kaiser FE; Morley JE; Nemo KJ; Padma-Nathan H; Place VA; Prendergast JJ; Tam PY; Tanagho EA; Todd LK; Varady JC; Gesundheit N
    J Urol; 1998 May; 159(5):1523-7; discussion 1527-8. PubMed ID: 9554347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association classes II and III congestive heart failure: a prospective, placebo-controlled, double-blind crossover trial.
    Webster LJ; Michelakis ED; Davis T; Archer SL
    Arch Intern Med; 2004 Mar; 164(5):514-20. PubMed ID: 15006828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term safety of alprostadil (prostaglandin-E1) in patients with erectile dysfunction. The European Alprostadil Study Group.
    Br J Urol; 1998 Oct; 82(4):538-43. PubMed ID: 9806184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Symposium on Edex (alprostadil) in the diagnosis and treatment of erectile dysfunction].
    Borisov VV
    Urol Nefrol (Mosk); 1995; (6):53. PubMed ID: 8686130
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience with intracavernous PGE-1 in the treatment of erectile dysfunction: dose considerations and efficacy.
    Ismail M; Abbott L; Hirsch IH
    Int J Impot Res; 1997 Mar; 9(1):39-42. PubMed ID: 9138057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy, safety and tolerability of intracavernous PNU-83757 for the treatment of erectile dysfunction.
    Vick RN; Benevides M; Patel M; Parivar K; Linnet O; Carson CC
    J Urol; 2002 Jun; 167(6):2618-23. PubMed ID: 11992097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A positive pharmacological erection test does not rule out arteriogenic erectile dysfunction.
    Cormio L; Nisén H; Selvaggi FP; Ruutu M
    J Urol; 1996 Nov; 156(5):1628-30. PubMed ID: 8863555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of linsidomine chlorhydrate, a direct nitric oxide donor, in the treatment of human erectile dysfunction: results of a double-blind cross over trial.
    Wegner HE; Knispel HH; Klän R; Miller K
    Int J Impot Res; 1995 Dec; 7(4):233-7. PubMed ID: 8770666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
    Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
    Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prostaglandin E1 (PGE1) in diagnosis and long-term therapy of erectile dysfunction].
    Derouet H; Weirauch A; Bewermeier H
    Urologe A; 1996 Jan; 35(1):62-7. PubMed ID: 8851852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The penis as a vascular organ. The importance of corporal smooth muscle tone in the control of erection.
    Christ GJ
    Urol Clin North Am; 1995 Nov; 22(4):727-45. PubMed ID: 7483125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.